## **Core Concept**
Chronic granulomatous disease (CGD) is a disorder characterized by the inability of phagocytic cells (like neutrophils and macrophages) to kill certain bacteria and fungi due to a defect in the production of reactive oxygen species (ROS). This defect results from mutations in the genes encoding the subunits of NADPH oxidase, an enzyme crucial for generating superoxides that help in microbial killing.
## **Why the Correct Answer is Right**
The correct answer, , is not typically associated with causing serious infections in individuals with CGD. Organisms that are commonly implicated in serious infections in CGD patients are usually catalase-positive bacteria and fungi, which include *Staphylococcus aureus*, *Escherichia coli*, *Klebsiella*, *Aspergillus*, and *Candida*. *Salmonella* species can cause infections but are less commonly emphasized as primary pathogens in CGD compared to the others listed.
## **Why Each Wrong Option is Incorrect**
* **Option A:** *Staphylococcus aureus* is a well-known pathogen in CGD, causing recurrent infections due to its ability to survive within phagocytic cells.
* **Option B:** *Aspergillus* species, particularly *Aspergillus fumigatus*, are notorious for causing severe fungal infections in CGD patients, often leading to pneumonia or disseminated disease.
* **Option C:** *Burkholderia cepacia* (though more commonly referred to in the context of cystic fibrosis) can cause infections in CGD but is less commonly listed; however, it still poses a risk.
## **Clinical Pearl / High-Yield Fact**
A key point to remember is that CGD patients are particularly susceptible to infections with catalase-positive organisms. A classic clinical clue is that CGD patients often present with recurrent lymphadenitis, hepatosplenomegaly, and severe infections, particularly with *Staphylococcus aureus* and *Aspergillus*.
## **Correct Answer:** .
Free Medical MCQs Β· NEET PG Β· USMLE Β· AIIMS
Access thousands of free MCQs, ebooks and daily exams.
By signing in you agree to our Privacy Policy.